Adma Biologics, Inc. planned insider sales
In the twelve months since 11 October 2025 insiders at Adma Biologics, Inc. filed 4 Form 144 notices of planned sales, 207,122 shares worth $3.3 million at the time of filing, from 3 sellers. The latest, filed 10 March 2026: Tade Brad L. (former officer), 50,026 shares worth $790,911, planned for around 10 March 2026 through Fidelity Brokerage Services, LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|
| 10 March 2026 | Tade Brad L. | Former Officer | 50,026 | $790,911 | 10 March 2026 | Fidelity Brokerage Services, LLC | Restricted Stock Units vesting - granted February 19, 2025; Restricted Stock Units vesting - granted February 26, 2024; Restricted Stock Units vesting - granted July 25, 2024; Restricted Stock Units vesting - granted June 26, 2023 | Form 144 |
| 9 March 2026 | Kestenberg-Messina Kaitlin M. | Officer | 10,096 | $155,377 | 9 March 2026 | Fidelity Brokerage Services, LLC | Stock Option Exercise - Options Granted August 19, 2020; Stock Option Exercise - Options Granted February 14, 2017; Stock Option Exercise - Options Granted February 25, 2021; Stock Option Exercise - Options Granted July 19, 2021; Stock Option Exercise - Options Granted June 5, 2019 | Form 144 |
| 17 February 2026 | Grossman Adam S. | Director, Officer | 84,000 | $1.4 million | 17 February 2026 | Fidelity Brokerage Services, LLC | Restricted Stock Units vesting - granted March 6, 2025; Restricted Stock Units vesting - granted March 7, 2025; Stock Option Exercise - Options Granted February 26, 2024; Stock Option Exercise - Options Granted March 06, 2023 | Form 144 |
| 24 October 2025 | Grossman Adam S. | Director and Officer | 63,000 | $960,750 | 24 October 2025 | Fidelity Brokerage Services, LLC | Restricted Stock Units vesting - granted March 6, 2023; Stock Option Exercise - Options | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read more
Value is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.Source
Form 144 filings on EDGAR for Adma Biologics, Inc.: the company's filing index, each notice read from its own XML.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.